Search

Your search keyword '"Hraiech, Sami"' showing total 31 results

Search Constraints

Start Over You searched for: Author "Hraiech, Sami" Remove constraint Author: "Hraiech, Sami" Topic adult respiratory distress syndrome Remove constraint Topic: adult respiratory distress syndrome
31 results on '"Hraiech, Sami"'

Search Results

1. Outcomes of Severe ARDS COVID-19 Patients Denied for Venovenous ECMO Support: A Prospective Observational Comparative Study.

2. COVID-19 among undocumented migrants admitted to French intensive care units during the 2020–2021 period: a retrospective nationwide study.

3. Response to Prone Position in COVID-19 and Non-COVID-19 Patients with Severe ARDS Supported by vvECMO.

4. High-Flow Versus VenturiMask Oxygen Therapy to Prevent Reintubation in Hypoxemic Patients after Extubation: A Multicenter Randomized Clinical Trial.

5. Impact of Dexamethasone and Inhaled Nitric Oxide on Severe Acute Kidney Injury in Critically Ill Patients with COVID-19.

6. Outcomes of Patients Presenting with Mild Acute Respiratory Distress Syndrome: Insights from the LUNG SAFE Study

7. Undocumented migrants in French intensive care units in 2011–2018: retrospective nationwide study.

8. Impact of obesity on survival in COVID-19 ARDS patients receiving ECMO: results from an ambispective observational cohort.

9. Myorelaxants in ARDS patients.

10. Herpes simplex virus and Cytomegalovirus reactivation among severe ARDS patients under veno-venous ECMO.

11. Transforming Growth Factor-β1 in predicting early lung fibroproliferation in patients with acute respiratory distress syndrome.

12. Impact of late administration of corticosteroids in COVID-19 ARDS.

13. Lack of viral clearance by the combination of hydroxychloroquine and azithromycin or lopinavir and ritonavir in SARS-CoV-2-related acute respiratory distress syndrome.

14. Effects of neuromuscular blockers on transpulmonary pressures in moderate to severe acute respiratory distress syndrome.

15. Neuromuscular blocking agents as part of lung-protective strategy in severe ARDS patients.

16. Prone positioning and extracorporeal membrane oxygenation for severe acute respiratory distress syndrome: time for a randomized trial?

17. Effect of high-frequency oscillatory ventilation on esophageal and transpulmonary pressures in moderate-to-severe acute respiratory distress syndrome.

18. Early Hepatic Dysfunction Is Associated with a Worse Outcome in Patients Presenting with Acute Respiratory Distress Syndrome: A Post-Hoc Analysis of the ACURASYS and PROSEVA Studies.

19. Type III procollagen is a reliable marker of ARDS-associated lung fibroproliferation.

20. Outcome of acute respiratory distress syndrome patients treated with extracorporeal membrane oxygenation and brought to a referral center.

22. Response to Huang et al. "Herpesviridae reactivation for poor outcome in ARDS patients with ECMO: criminal or witness?".

24. Characteristics and outcomes of acute respiratory distress syndrome related to COVID-19 in Belgian and French intensive care units according to antiviral strategies: the COVADIS multicentre observational study.

25. Transpulmonary pressures in obese and non-obese COVID-19 ARDS.

26. Chest CT scan and alveolar procollagen III to predict lung fibroproliferation in acute respiratory distress syndrome.

27. Right ventricular function during high-frequency oscillatory ventilation in adults with acute respiratory distress syndrome.

28. Venous Thromboembolism Events Following Venovenous Extracorporeal Membrane Oxygenation for Severe Acute Respiratory Syndrome Coronavirus 2 Based on CT Scans.

29. Prevalence and Risk Factors for Thrombotic Complications Following Venovenous Extracorporeal Membrane Oxygenation: A CT Scan Study.

30. Resolved versus confirmed ARDS after 24 h: insights from the LUNG SAFE study

31. National incidence rate and related mortality for acute respiratory distress syndrome in France.

Catalog

Books, media, physical & digital resources